<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24796" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>McArdle Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khattak</surname>
            <given-names>Zoia E.</given-names>
          </name>
          <aff>Khyber Medical University, Pakistan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lam</surname>
            <given-names>Justin Riley</given-names>
          </name>
          <aff>Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashraf</surname>
            <given-names>Muddasir</given-names>
          </name>
          <aff>Trinity Medical Center, Rock Island IL</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zoia Khattak declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Justin Riley Lam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muddasir Ashraf declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24796.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>McArdle disease is a genetic disorder that mainly affects skeletal muscles. It occurs due to the deficiency or absence of an enzyme called myophosphorylase. Symptoms like painful muscle cramps, weakness, and fatigue manifest during periods of physical activity. To avoid the unpleasant symptoms associated with this condition and improve the quality of life, the disease requires prompt diagnosis and treatment. This activity reviews the evaluation and management of McArdle disease and highlights the role of the interprofessional team in improving the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the etiology of McArdle disease.</p></list-item><list-item><p>Summarize the appropriate steps in the evaluation of McArdle disease.</p></list-item><list-item><p>Describe the treatment options currently available for McArdle disease.</p></list-item><list-item><p>Identify and discuss interprofessional team strategies to improve patient care coordination and communication to manage McArdle disease and improve disease outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24796&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24796">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24796.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>McArdle disease, also known as glycogen storage disorder (GSD) type V, is an inborn metabolic disorder characterized by a deficiency or complete absence of an enzyme called muscle glycogen phosphorylase (or myophosphorylase). This disease is inherited in an autosomal recessive pattern and mainly affects skeletal muscles. The enzyme responsible for this disease normally catalyzes reactions that cause the conversion of glycogen to glucose. The deficiency of this enzyme, in turn, results in the accumulation of glycogen in tissues. The clinical sequelae are usually systemic, but the defect is limited to particular tissues in some cases.&#x000a0;Glycolysis is only partially&#x000a0;hindered in McArdle disease, as muscle fibers&#x000a0;are able&#x000a0;to convert glucose to glucose-6-phosphate (G6P) downstream of the metabolic block.<xref ref-type="bibr" rid="article-24796.r1">[1]</xref></p>
        <p>Most patients with GSDs&#x000a0;present in childhood; however, McArdle disease is one of those that have adult-onset forms as well. Unfortunately, there have not been any established treatment options, although diet therapy has been observed to be efficacious in reducing clinical manifestations.</p>
        <p>McArdle disease was first&#x000a0;reported&#x000a0;in 1951 by Dr. Brian McArdle from London.<xref ref-type="bibr" rid="article-24796.r2">[2]</xref> In 1959, it was described that the enzyme responsible for the affected step was myophosphorylase.<xref ref-type="bibr" rid="article-24796.r3">[3]</xref><xref ref-type="bibr" rid="article-24796.r4">[4]</xref>&#x000a0;The underlying gene for myophosphorylase (PYGM) was first discovered in 1984.<xref ref-type="bibr" rid="article-24796.r5">[5]</xref></p>
      </sec>
      <sec id="article-24796.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>McArdle disease typically results from mutations involving the muscle-specific isoform of the glycogen phosphorylase enzyme (abbreviated as PGYM). This enzyme plays a key role in the first step of glycogenolysis, that releases glucose-1-phosphate monomers in muscle fibers. As a result, the carbohydrate metabolism of the skeletal muscle is affected, and energy cannot be generated from the glycogen stores of muscles. The genetic mutations of the PYGM gene on 11q13 make the enzyme inactive.<xref ref-type="bibr" rid="article-24796.r6">[6]</xref> Exons 1 and 17 particularly exhibit mutation hotspots; half of the cases are nonsense mutations. The commonest mutation in White individuals is described as p.Arg50Stop or R50X.<xref ref-type="bibr" rid="article-24796.r7">[7]</xref><xref ref-type="bibr" rid="article-24796.r8">[8]</xref></p>
        <p>From the study of the genetics of McArdle disease, 179 variants have been identified that together affect&#x000a0;the PYGM gene. Missense mutations have been found to be the most common variants in European and US White populations (around 60% of all mutations). It has been reported that the majority of the patients do not have myophosphorylase, regardless&#x000a0;of the type of mutation, such as missense, nonsense, insertion,&#x000a0;deletion, and splicing.<xref ref-type="bibr" rid="article-24796.r9">[9]</xref> This indicates the absence of myophosphorylase activity when there is a PYGM mutation, except for those rare cases where missense mutations&#x000a0;result in preserved myophosphorylase activity and better&#x000a0;phenotypes.<xref ref-type="bibr" rid="article-24796.r10">[10]</xref></p>
      </sec>
      <sec id="article-24796.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact prevalence of McArdle disease is not precisely known and appears to range from 1 in 50,000 to 1 in 200,000 in the United States. The variation between the prevalence according to genetic data and the prevalence according to diagnosed cases is attributable to the delay in making a diagnosis. One study analyzed gene frequency and next-generation sequencing data to report the true prevalence of the disease among populations. The results of that study revealed that the disease is much more common than previously thought and has a prevalence of 1 in 7,650 (95% confidence interval (CI) 1/5,362-1/11,108). An additional method used by the same study looked at the two most common mutations and recorded a prevalence of 1 in 42,355.<xref ref-type="bibr" rid="article-24796.r11">[11]</xref><xref ref-type="bibr" rid="article-24796.r8">[8]</xref></p>
        <p>In some areas of the USA, such as the Dallas/Fort Worth area, the prevalence of McArdle disease on the basis of genetic data is reported to be 1/100000.<xref ref-type="bibr" rid="article-24796.r12">[12]</xref> A study in Spain reported the prevalence of diagnosed cases to be around 1/139543.<xref ref-type="bibr" rid="article-24796.r13">[13]</xref></p>
        <p>In&#x000a0;terms of gender, in&#x000a0;McArdle disease, the following ratios of men to women have been noted:</p>
        <list list-type="bullet">
          <list-item>
            <p>Spain 55:45<xref ref-type="bibr" rid="article-24796.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Italy 65:35<xref ref-type="bibr" rid="article-24796.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>UK 50:50<xref ref-type="bibr" rid="article-24796.r15">[15]</xref></p>
          </list-item>
        </list>
        <p>In terms of age, most McArdle disease cases present in the second or third decade of life. Wolfe et al. report a unique&#x000a0;precedent of McArdle disease&#x000a0;manifesting in a 73-year-old patient.<xref ref-type="bibr" rid="article-24796.r16">[16]</xref>&#x000a0;Felice and Pourmand also reported late presentations. Providers should consider the diagnosis of McArdle disease regardless of the age of presentation.<xref ref-type="bibr" rid="article-24796.r17">[17]</xref><xref ref-type="bibr" rid="article-24796.r18">[18]</xref></p>
      </sec>
      <sec id="article-24796.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Myophosphorylase is a key enzyme in the regulation of glucose metabolism in muscles. It detaches 1,4 glycosyl chains from glycogen and attaches inorganic phosphate to form glucose-1-phosphate. During glycogen breakdown, muscle cells generate glucose-1-phosphate in place of glucose, and due to the polar nature of the former molecule, it disintegrates intracellularly.</p>
        <p>PYG is activated when phosphorylated by the enzyme phosphorylase kinase. Glucagon and adrenaline initiate glycogenolysis in the liver, binding to G-protein coupled receptors first. The signaling pathway behind this process involves the following steps: GPCRs (G-protein coupled receptors) - AC (adenylate cyclase) &#x02013; cAMP (cyclic adenosine monophosphate) &#x02013; PKA (protein kinase A) &#x02013; PK (phosphorylase kinase) causing PYG activation. In contrast, PYG becomes inactivated when dephosphorylated by a different enzyme called protein phosphatase 1 (PP1).<xref ref-type="bibr" rid="article-24796.r7">[7]</xref></p>
        <p>There are several tissue-specific isoforms of phosphorylase. Myophosphorylase is found in cardiac myocytes and the brain, and it is the only&#x000a0;variant present in skeletal muscle. Most patients with McArdle disease lack myophosphorylase activity; therefore, they are unable to produce energy in the form of glucose by breaking down glycogen stores in muscles.<xref ref-type="bibr" rid="article-24796.r19">[19]</xref></p>
        <p>During aerobic&#x000a0;activity, such as walking, jogging, gentle swimming, or cycling, the skeletal muscle derives energy from free fatty acids by oxidizing them in the mitochondria via the beta-oxidation pathway to&#x000a0;form acetyl-CoA. Acetyl-CoA is further metabolized via the Krebs cycle and the respiratory chain, leading to the production of adenosine triphosphate (ATP). During anaerobic activity, such as weightlifting or sprinting, the myophosphorylase of the skeletal muscle&#x000a0;breaks down glycogen to glucose, which then enters the glycolytic pathway yielding ATP anaerobically.<xref ref-type="bibr" rid="article-24796.r20">[20]</xref></p>
      </sec>
      <sec id="article-24796.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>To support the diagnosis, muscle tissue is biopsied and examined under a microscope. The hallmark findings suggestive of McArdle disease are glycogen deposits and the absence of the enzyme myophosphorylase.<xref ref-type="bibr" rid="article-24796.r21">[21]</xref></p>
        <p>Glycogen deposits appear under the sarcolemmal membrane at the periphery of myofibers. The collection of glycogen between myofibrils makes the myofibers look like vacuoles. The glycogen takes up periodic acid-Schiff (PAS). The absence of glycogen accumulation in muscle biopsy should not be taken as proof for the absence of McArdle disease, as the glycogen could be washed out in tissue processing.</p>
        <p>Myophosphorylase&#x000a0;histochemistry is easier to perform and has a good negative predictive value. Its absence is diagnostic for McArdle disease. However,&#x000a0;providers must specifically request the testing of myophosphorylase.</p>
      </sec>
      <sec id="article-24796.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The most frequently reported symptom remains physical activity intolerance. Other symptoms include painful muscle cramps, weakness, and fatigue. Muscle pain and stiffness sometimes can lead to painful contractures. All these symptoms are much more pronounced soon after starting activity and alleviated with exercise cessation. In cases of sudden, persistent muscle contraction during high-intensity exercise, severe muscle damage can occur, resulting in a massive release of muscle proteins, i.e., creatinine kinase (typical level &#x0003e;1,000 U/l) and myoglobin in blood, as well as myoglobinuria (excretion of myoglobin in urine) presenting as dark-colored urine. In rare instances, acute renal failure and catastrophic hyperkalemia can ensue from an episode of rhabdomyolysis (muscle breakdown).<xref ref-type="bibr" rid="article-24796.r22">[22]</xref></p>
        <p>A unique feature associated with this disorder called the &#x0201c;second-wind phenomenon&#x0201d; is seen in most patients and is characterized by improved symptoms after approximately 10 minutes of&#x000a0;gentle aerobic&#x000a0;activity.<xref ref-type="bibr" rid="article-24796.r8">[8]</xref></p>
        <p>McArdle disease usually presents in the&#x000a0;first or second&#x000a0;decade of life. Patients more than 40 years of age complain of weakness and wasting of muscles.<xref ref-type="bibr" rid="article-24796.r23">[23]</xref><xref ref-type="bibr" rid="article-24796.r24">[24]</xref><xref ref-type="bibr" rid="article-24796.r8">[8]</xref><xref ref-type="bibr" rid="article-24796.r7">[7]</xref><xref ref-type="bibr" rid="article-24796.r21">[21]</xref></p>
        <p>Clinical heterogeneity is widely seen in McArdle disease. Some patients present with very mild symptoms, such as tiredness without cramps. On the other hand, progressive weakness ensues in the 6th or 7th decade of life. Contrary to this, fatal infantile McArdle syndrome, which is&#x000a0;the severe and rapidly progressive form, appears shortly after birth.</p>
        <p>Seizures have been described in 4% of patients.</p>
        <p>Classic McArdle disease presents with the following examination findings:</p>
        <list list-type="bullet">
          <list-item>
            <p>Proximal muscle weakness - most notable following exercise</p>
          </list-item>
          <list-item>
            <p>Fixed limb weakness - usually in the proximal muscle groups</p>
          </list-item>
          <list-item>
            <p>Muscle wasting</p>
          </list-item>
        </list>
        <p>The fatal infantile variant can have the following examination findings:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypotonia</p>
          </list-item>
          <list-item>
            <p>Diminished deep tendon reflexes</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24796.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial assessment in suspected cases is done using a forearm exercise test. As the process of glycogenolysis is defective, no pyruvate and subsequent lactate are produced through normal pathways. Isometric rhythmic exercises are done for one minute, and the levels of lactate and ammonia before and after are compared.</p>
        <p>During normal circumstances, a three-fold rise in lactate and ammonia occurs, but lactate rise is remarkably low in glycolytic and glycogenolytic disorders. The ischemic test making use of a sphygmomanometer cuff is obsolete now, and there is a recent consensus on the use of nonischemic forearm exercise tests to avoid unfavorable outcomes like rhabdomyolysis and compartment syndrome.<xref ref-type="bibr" rid="article-24796.r25">[25]</xref>&#x000a0;The test has&#x000a0;fairly high sensitivity and specificity; therefore, a normal test result rules out the possibility of a glycolytic/glycogenolytic defect.&#x000a0;Nonischemic forearm testing&#x000a0;is equally diagnostic, with a lesser risk of compartment syndrome. These tests are performed in the same way but with no use of a blood pressure cuff.<xref ref-type="bibr" rid="article-24796.r26">[26]</xref>&#x000a0;The nonischemic test has a sensitivity of 100% and a specificity of 100% and 99.7%, respectively, as has been reported by a 2015 retrospective study.<xref ref-type="bibr" rid="article-24796.r27">[27]</xref></p>
        <p>A characteristic feature of McArdle disease is the chronically elevated serum creatine kinase (CK) enzyme levels.</p>
        <p>Graded exercise stress is done to demonstrate the second-wind phenomenon, often seen in patients with McArdle disease, and also to distinguish it from disorders of glycolytic pathways.</p>
        <p>Muscle biopsy (vastus lateralis or biceps brachialis) shows periodic acid Schiff-positive vacuoles of high glycogen content and absence of myophosphorylase. Genetic testing includes options of specific mutation analysis (most commonly R50X in the White population), next-generation PYGM gene sequencing panels, myopathy panels, or whole-exome sequencing for particular glycogen-storage diseases. Typically, patients are diagnosed based on whether they are homozygous or compound heterozygous for PYGM pathogenic mutations. A study aimed to formulate a less invasive approach to diagnose the disease and found out PYGM expression in white blood cells by using antibodies.</p>
        <p>Other tests done to support the findings are serum uric acid levels (high in about half of the cases), urinalysis for detecting pigmenturia, and electromyography, which often yields normal findings.<xref ref-type="bibr" rid="article-24796.r8">[8]</xref><xref ref-type="bibr" rid="article-24796.r28">[28]</xref><xref ref-type="bibr" rid="article-24796.r26">[26]</xref><xref ref-type="bibr" rid="article-24796.r6">[6]</xref><xref ref-type="bibr" rid="article-24796.r21">[21]</xref></p>
      </sec>
      <sec id="article-24796.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment is mostly geared towards avoiding lifestyle activities that exacerbate the symptoms. Patients may adapt to avoiding physical activity, but this may worsen the disease because serum CK rises with loss of aerobic fitness. It may also result in the decreased capacity of muscles to utilize alternate fuels to overcome the block in glycogenolysis. Moreover, there is a marked reduction in the expression of proteins needed for metabolism and calcium hemostasis in non-exercising muscles.</p>
        <p>There is evidence proving the beneficial effects of moderate-intensity graded aerobic exercise therapy. Patients reported less significant exercise intolerance and earlier appearance of second wind with this intervention. A balanced weight-lifting approach also lessens the severity of symptoms in some patients.</p>
        <p>Howell et al. proposed that sodium valproate could cause the up-regulation of the myophosphorylase enzyme. The findings&#x000a0;of that study suggested that sodium valproate could be a potential management option for McArdle disease; however, more randomized trials are needed.<xref ref-type="bibr" rid="article-24796.r29">[29]</xref></p>
        <p>It&#x000a0;has been noted that creatine may improve ATP storage and exercise tolerability. However, in a trial, high-dose creatine monohydrate resulted in poor exercise tolerance and a significant increase in exercise-induced myalgia. The investigators proposed an&#x000a0;explanation that inadequate adaptation to better electromechanical efficacy results in excess muscle contractility during exercise and, thus, a resultant worsening of symptoms.<xref ref-type="bibr" rid="article-24796.r30">[30]</xref></p>
        <p>Certain dietary interventions that confer favorable effects include taking a sugary meal before planned exercise&#x02014;for example, having a drink containing 37 g sucrose 5 minutes before exercise reduces initial symptoms of exercise intolerance. A diet rich in carbohydrates results in much better outcomes in comparison to a protein-rich diet. Other nutritional agents that were helpful for some patients but could not yield convincing outcomes during actual experimental studies include branched-chain amino acids, depot glucagon preparations, verapamil, dantrolene sodium, vitamin B6, high dose D-ribose, and high-dose creatine ingestion.<xref ref-type="bibr" rid="article-24796.r31">[31]</xref><xref ref-type="bibr" rid="article-24796.r24">[24]</xref><xref ref-type="bibr" rid="article-24796.r22">[22]</xref><xref ref-type="bibr" rid="article-24796.r32">[32]</xref><xref ref-type="bibr" rid="article-24796.r8">[8]</xref><xref ref-type="bibr" rid="article-24796.r33">[33]</xref></p>
      </sec>
      <sec id="article-24796.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is essential to distinguish McArdle disease from other glycogen storage disorders as well as other diseases inducing myopathy, particularly fatty acid oxidation defects, and mitochondrial myopathies.</p>
        <p>McArdle disease demonstrates its symptoms at the very beginning of rigorous physical activity, whereas fatty acid oxidation defects (carnitine palmitoyltransferase II deficiency) and mitochondrial myopathies (Medium-chain acyl-CoA dehydrogenase deficiency) show symptoms much later with a longer duration of the exercise. Moreover, fatty acid oxidation defects manifest their symptoms under stressful states such as fasting, fever, and infections.</p>
        <p>A noteworthy phenomenon occurring with McArdle disease is the second wind phenomenon (lesser perception of discomfort), and it does not occur in other conditions mimicking McArdle disease.</p>
        <p>Patients with McArdle disease have chronically high serum creatine kinase levels. This enzyme may or may not be elevated in other glycogen storage diseases, fatty acid oxidation defects, and mitochondrial myopathies.</p>
        <p>Generally, a carbohydrate-rich meal before exercise decreases the symptom severity in McArdle disease and fatty acid oxidation defects but does not prove helpful in mitochondrial myopathies and worsens symptoms in the glycolytic pathway disorder.</p>
        <p>Muscle biopsy and genetic testing further delineate the difference between the disorders mentioned above. On biopsy, McArdle disease shows high glycogen content, carnitine palmitoyltransferase II deficiency shows increased lipids, and mitochondrial myopathy shows ragged red fibers and cytochrome oxidase negative fibers. Specific mutation analysis reveals the most common mutations to be R50X, S113L, and m.3243A&#x0003e;G in McArdle disease, fatty acid oxidation disorders, and mitochondrial defects, respectively.<xref ref-type="bibr" rid="article-24796.r21">[21]</xref></p>
      </sec>
      <sec id="article-24796.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most of the patients affected with McArdle disease lead a normal life, and it does not affect life expectancy. Rhabdomyolysis is to be avoided as it can lead to acute renal failure, which may potentially become life-threatening. Patients exploit the second wind phenomenon and adjust to the disease itself. Only a minority of patients have been known to experience progressive worsening of symptoms with advancing age and wasting, especially over the shoulder girdle and back muscles.<xref ref-type="bibr" rid="article-24796.r24">[24]</xref></p>
        <p>More recent studies&#x000a0;report heterogeneity in the clinical severity, such as 8% of patients are asymptomatic in daily life, and 21% show limitations in the activities of daily living and fixed muscle weakness.<xref ref-type="bibr" rid="article-24796.r13">[13]</xref>The evidence also&#x000a0;reiterates&#x000a0;acquiring an active lifestyle, which is critical in patients with McArdle disease.<xref ref-type="bibr" rid="article-24796.r13">[13]</xref></p>
        <p>It has also been reported in various studies that&#x000a0;the disease does not adversely&#x000a0;alter&#x000a0;the course of pregnancy or childbirth.<xref ref-type="bibr" rid="article-24796.r22">[22]</xref></p>
      </sec>
      <sec id="article-24796.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Rhabdomyolysis is an established complication of McArdle disease.<xref ref-type="bibr" rid="article-24796.r34">[34]</xref>&#x000a0;Acute renal failure may result from myoglobinuria after vigorous exercise. As with any patient having rhabdomyolysis, patients with McArdle disease should be monitored for the possible complications of electrolyte abnormalities, compartment syndrome, and metabolic encephalopathy.<xref ref-type="bibr" rid="article-24796.r35">[35]</xref></p>
      </sec>
      <sec id="article-24796.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>In McArdle disease, rhabdomyolysis may be followed by acute renal failure, necessitating consultation with a renal physician. Renal function should be monitored in all McArdle disease cases.</p>
      </sec>
      <sec id="article-24796.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Upon diagnosis of the condition, it is essential to refer the patient to a clinical geneticist/genetic counselor. Annual surveillance includes routine physical examinations and diet checks. Counseling consists of avoiding certain exercises, eg, sustained hand grip exercises, weight lifting unless under a specialist's supervision, competitive ball games, running, exercises involving excessive jumping, strenuous swimming, and cycling.<xref ref-type="bibr" rid="article-24796.r23">[23]</xref><xref ref-type="bibr" rid="article-24796.r13">[13]</xref><xref ref-type="bibr" rid="article-24796.r8">[8]</xref><xref ref-type="bibr" rid="article-24796.r24">[24]</xref></p>
        <p>Limitation or adaptation of physical activity to avoid symptoms is necessary, as rhabdomyolysis is a life-threatening condition.</p>
        <p>There is a mild&#x000a0;risk of acute muscle necrosis secondary to certain general anesthetics, such as muscle relaxants and inhaled anesthetic agents.&#x000a0;This should be taken care of while treating patients with&#x000a0;McArdle disease to avoid rhabdomyolysis.<xref ref-type="bibr" rid="article-24796.r36">[36]</xref></p>
      </sec>
      <sec id="article-24796.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>GSD type V is an autosomal recessive disease, and patients should be aware of its inheritance pattern and risk in future generations. Homozygous persons are symptomatic, while heterozygous individuals carry affected genes and transmit them to their offspring.</p>
        <p>A consultation with a genetic specialist is critical in such circumstances. Optional genetic testing could be offered to the relatives (particularly siblings) of an affected individual. The autosomal recessive inheritance means that the parents are the carriers of the disease and have mild or no symptoms. Each sibling carries a 1&#x000a0;in 4 chance of being affected, a 1 in 2 chance of being a carrier, and a 1 in 4 chance of being unaffected and non-carrier.</p>
        <p>Appropriate family planning is necessary for affected individuals, carriers, or individuals at high risk of being carriers. All available options require collaborative exploration with the patient, including information about prenatal testing and preimplantation genetic testing before becoming pregnant.<xref ref-type="bibr" rid="article-24796.r23">[23]</xref></p>
      </sec>
      <sec id="article-24796.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24796&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24796">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/mcardle-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24796">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24796/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24796">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24796.s17">
        <title>References</title>
        <ref id="article-24796.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>&#x000d8;rtenblad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brull</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Luna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pin&#x000f3;s</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>McArdle disease: a unique study model in sports medicine.</article-title>
            <source>Sports Med</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>44</volume>
            <issue>11</issue>
            <fpage>1531</fpage>
            <page-range>1531-44</page-range>
            <pub-id pub-id-type="pmid">25028051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McARDLE</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Myopathy due to a defect in muscle glycogen breakdown.</article-title>
            <source>Clin Sci</source>
            <year>1951</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-35</page-range>
            <pub-id pub-id-type="pmid">24540673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mommaerts</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Illingworth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Guillory</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Seraydarian</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1959</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>791</fpage>
            <page-range>791-7</page-range>
            <pub-id pub-id-type="pmid">16590445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SCHMID</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>MAHLER</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle.</article-title>
            <source>J Clin Invest</source>
            <year>1959</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>11</issue>
            <fpage>2044</fpage>
            <page-range>2044-58</page-range>
            <pub-id pub-id-type="pmid">14442994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebo</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Gorin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fletterick</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Kan</surname>
                <given-names>YW</given-names>
              </name>
            </person-group>
            <article-title>High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11.</article-title>
            <source>Science</source>
            <year>1984</year>
            <month>Jul</month>
            <day>06</day>
            <volume>225</volume>
            <issue>4657</issue>
            <fpage>57</fpage>
            <page-range>57-9</page-range>
            <pub-id pub-id-type="pmid">6587566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Luna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brull</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garatachea</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pin&#x000f3;s</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?</article-title>
            <source>Neuromuscul Disord</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>1079</fpage>
            <page-range>1079-86</page-range>
            <pub-id pub-id-type="pmid">25240406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Llavero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arrazola Sastre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Luque Montoro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000e1;lvez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lacerda</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Parada</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Zugaza</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Nov</month>
            <day>25</day>
            <volume>20</volume>
            <issue>23</issue>
            <pub-id pub-id-type="pmid">31775340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Godfrey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coll-Cant&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pintos-Morell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pin&#x000f3;s</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genes and exercise intolerance: insights from McArdle disease.</article-title>
            <source>Physiol Genomics</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-100</page-range>
            <pub-id pub-id-type="pmid">26465709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Consuegra</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Asensio-Pe&#x000f1;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ballester-Lopez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Francisco-Velilla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pinos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pintos-Morell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coll-Cant&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Quintana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Missense mutations have unexpected consequences: The McArdle disease paradigm.</article-title>
            <source>Hum Mutat</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>10</issue>
            <fpage>1338</fpage>
            <page-range>1338-1343</page-range>
            <pub-id pub-id-type="pmid">30011114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vissing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.</article-title>
            <source>Brain</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>132</volume>
            <issue>Pt 6</issue>
            <fpage>1545</fpage>
            <page-range>1545-52</page-range>
            <pub-id pub-id-type="pmid">19433441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Castro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biesecker</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data.</article-title>
            <source>Genet Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>1002</fpage>
            <page-range>1002-6</page-range>
            <pub-id pub-id-type="pmid">25741863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haller</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Treatment of McArdle disease.</article-title>
            <source>Arch Neurol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>923</fpage>
            <page-range>923-4</page-range>
            <pub-id pub-id-type="pmid">10891971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Encinar</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Vieitez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Quintana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Serrano-Lorenzo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Consuegra</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Asensio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ballester-Lopez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pintos-Morell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coll-Cant&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pareja-Galeano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>D&#x000ed;ez-Bermejo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pin&#x000f3;s</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update.</article-title>
            <source>BMC Genomics</source>
            <year>2017</year>
            <month>Nov</month>
            <day>14</day>
            <volume>18</volume>
            <issue>Suppl 8</issue>
            <fpage>819</fpage>
            <pub-id pub-id-type="pmid">29143597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cassandrini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Martinuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toscano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moggio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Servidei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mongini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Musumeci</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Lamperti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Filosto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Minetti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.</article-title>
            <source>Hum Mutat</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>718</fpage>
            <pub-id pub-id-type="pmid">16786513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinlivan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Twist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Duno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vissing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cassandrini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sewry</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>McArdle disease: a clinical review.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>81</volume>
            <issue>11</issue>
            <fpage>1182</fpage>
            <page-range>1182-8</page-range>
            <pub-id pub-id-type="pmid">20861058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfe</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>McArdle's disease presenting with asymmetric, late-onset arm weakness.</article-title>
            <source>Muscle Nerve</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>641</fpage>
            <page-range>641-5</page-range>
            <pub-id pub-id-type="pmid">10716777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Felice</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Schneebaum</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>McArdle's disease with late-onset symptoms: case report and review of the literature.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1992</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>407</fpage>
            <page-range>407-8</page-range>
            <pub-id pub-id-type="pmid">1602316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pourmand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Corwin</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Late-onset Mcardle's disease with unusual electromyographic findings.</article-title>
            <source>Arch Neurol</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>374</fpage>
            <page-range>374-7</page-range>
            <pub-id pub-id-type="pmid">6573876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dimaur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hadjigeorgiou</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Myophosphorylase deficiency (glycogenosis type V; McArdle disease).</article-title>
            <source>Curr Mol Med</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-96</page-range>
            <pub-id pub-id-type="pmid">11949935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Godfrey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Quinlivan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skeletal muscle disorders of glycogenolysis and glycolysis.</article-title>
            <source>Nat Rev Neurol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>393</fpage>
            <page-range>393-402</page-range>
            <pub-id pub-id-type="pmid">27231184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarnopolsky</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Metabolic Myopathies.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6, Muscle and Neuromuscular Junction Disorders</issue>
            <fpage>1829</fpage>
            <page-range>1829-1851</page-range>
            <pub-id pub-id-type="pmid">27922496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Consuegra</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cabello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teijeira</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vieitez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>83</volume>
            <issue>3</issue>
            <fpage>322</fpage>
            <page-range>322-8</page-range>
            <pub-id pub-id-type="pmid">22250184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r23">
          <label>23</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <chapter-title>Glycogen Storage Disease Type V</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2006</year>
            <month>4</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">20301518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinlivan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinuzzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Nov</month>
            <day>12</day>
            <volume>2014</volume>
            <issue>11</issue>
            <fpage>CD003458</fpage>
            <pub-id pub-id-type="pmid">25391139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>McArdle disease: what do neurologists need to know?</article-title>
            <source>Nat Clin Pract Neurol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>10</issue>
            <fpage>568</fpage>
            <page-range>568-77</page-range>
            <pub-id pub-id-type="pmid">18833216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazemi-Esfarjani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Skomorowska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Vissing</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A nonischemic forearm exercise test for McArdle disease.</article-title>
            <source>Ann Neurol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-9</page-range>
            <pub-id pub-id-type="pmid">12210784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hogrel</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>van den Bogaart</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ledoux</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ollivier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Koujah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>B&#x000e9;hin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stojkovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eymard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Voermans</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lafor&#x000ea;t</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V.</article-title>
            <source>Eur J Neurol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>933</fpage>
            <page-range>933-40</page-range>
            <pub-id pub-id-type="pmid">25740218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanisch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Eger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bork</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lehnich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Deschauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zierz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Lactate production upon short-term non-ischemic forearm exercise in mitochondrial disorders and other myopathies.</article-title>
            <source>J Neurol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>253</volume>
            <issue>6</issue>
            <fpage>735</fpage>
            <page-range>735-40</page-range>
            <pub-id pub-id-type="pmid">16619130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dunton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Creed</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Quinlivan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sewry</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Investigating sodium valproate as a treatment for McArdle disease in sheep.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-9</page-range>
            <pub-id pub-id-type="pmid">25455802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vorgerd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zange</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grehl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>H&#x000fc;sing</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>J&#x000e4;ger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mortier</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fabian</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Malin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Luttmann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.</article-title>
            <source>Arch Neurol</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-101</page-range>
            <pub-id pub-id-type="pmid">11790236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Vissing</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>79</volume>
            <issue>12</issue>
            <fpage>1359</fpage>
            <page-range>1359-63</page-range>
            <pub-id pub-id-type="pmid">19010947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nogales-Gadea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Consuegra-Garc&#x000ed;a</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cuadros</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Camara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Torres-Torronteras</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fiuza-Luces</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Arum&#x000ed;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Andreu</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>A transcriptomic approach to search for novel phenotypic regulators in McArdle disease.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e31718</fpage>
            <pub-id pub-id-type="pmid">22347505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mungu&#x000ed;a-Izquierdo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brea-Alejo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pagola-Aldaz&#x000e1;bal</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>D&#x000ed;ez-Bermejo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fleck</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lucia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits.</article-title>
            <source>Front Aging Neurosci</source>
            <year>2014</year>
            <volume>6</volume>
            <fpage>334</fpage>
            <pub-id pub-id-type="pmid">25566067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satoh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hirashio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Irifuku</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishibashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Motoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sueda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Masaki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis.</article-title>
            <source>CEN Case Rep</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>194</fpage>
            <page-range>194-199</page-range>
            <pub-id pub-id-type="pmid">30900170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mull</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Myckatyn</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Kells</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Recurrent Compartment Syndrome Leading to the Diagnosis of McArdle Disease: Case Report.</article-title>
            <source>J Hand Surg Am</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>12</issue>
            <fpage>2377</fpage>
            <page-range>2377-9</page-range>
            <pub-id pub-id-type="pmid">26612634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bollig</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>McArdle's disease (glycogen storage disease type V) and anesthesia--a case report and review of the literature.</article-title>
            <source>Paediatr Anaesth</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>817</fpage>
            <page-range>817-23</page-range>
            <pub-id pub-id-type="pmid">23565573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shiraishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Effects of temperature on development and growth in the tick, Haemaphysalis longicornis.</article-title>
            <source>Exp Appl Acarol</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">3453334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nascimento</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinho</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pimenta de Castro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernardino Vieira</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>McArdle's Disease: A Differential Diagnosis of Metabolic Myopathies.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>e70000</fpage>
            <pub-id pub-id-type="pmid">39318660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24796.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Scanning electron microscopy of purified elastin with and without enzymatic digestion.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>1977</year>
            <volume>79</volume>
            <fpage>71</fpage>
            <page-range>71-96</page-range>
            <pub-id pub-id-type="pmid">868668</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
